Action of new organometallic complexes against Leishmania donovani

Journal of Antimicrobial Chemotherapy

Volumn 40, Issue 1, 1997, Pages 47-57

  Mesa Valle, C M ^a   Moraleda, V ^a   Lazuen, J ^b   Craciunescu, D ^c   Osuna, A ^b  

^a UNIVERSITY OF ALMERÍA   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

^c UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPROTOZOAL AGENT; NIFURTIMOX; ORGANOMETALLIC COMPOUND; OXAMNIQUINE; PENTAMIDINE DERIVATIVE;

ANTIPROTOZOAL ACTIVITY; ARTICLE; CYTOLYSIS; LEISHMANIA DONOVANI; NONHUMAN; PROMASTIGOTE;

ANIMALS; CHROMATIN; CRICETINAE; DNA, PROTOZOAN; DRUG EVALUATION, PRECLINICAL; GUANETHIDINE; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; MACROPHAGES; MICE; MITOCHONDRIA; NIFURTIMOX; ORGANOMETALLIC COMPOUNDS; ORGANOPLATINUM COMPOUNDS; OXAMNIQUINE; RATS; RATS, WISTAR; RNA, PROTOZOAN; SPLEEN; STRUCTURE-ACTIVITY RELATIONSHIP; TOXICITY TESTS;

EID: 0030813892     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/40.1.47     Document Type: Article

References (43)

1. World Health Organization. (1991). AIDS, leishmaniasis dangers of clash highlighted. TDR News 36, 1, 11.
2. Bryceson, A. (1987). Therapy in man. In The Leishmaniases in Biology and Medicine, Volume II: Clinical Aspects and Control (Peters, W. & Killick-Kendrick, R., Eds), pp. 847-907. Academic Press, London.
3. Steck, E. A. (1974). The leishmaniases. Progress in Drug Research 18, 289-351.
4. Trotter, E. R., Peters, W. & Robinson, B. L. (1980). The experimental chemotherapy of leishmaniasis, IV. The development of a rodent model for visceral infection. Annals of Tropical Medicine and Parasitology 74, 127-38.
5. Berman, J. D. (1981). Activity of imidazoles against Leishmania tropica in human macrophage cultures. American Journal of Tropical Medicine and Hygiene 31, 566-9.
6. Berman, J. D., Chulay, J. D., Hendricks, L. D. & Oster, C. N. (1982). Susceptibility of clinically sensitive and resistant Leishmania to pentavalent antimony in vitro. American Journal of Tropical Medicine and Hygiene 31, 459-65.
7. Croft, S. L., Davidson, R. N. & Thornton, E. A. (1991). Liposomal amphotericin B in the treatment of visceral leishmaniasis. Journal of Antimicrobial Chemotherapy 28, Suppl. A, 111-8.
8. Bryceson, A. D. M. (1970). Diffuse cutaneous leishmaniasis in Ethiopia. II. Treatment. Transactions of the Royal Society of Tropical Medicine and Hygiene 64, 369-79.
9. Strobel, M., Marchand, J. P. & Dedet, J. P. (1979). Le traitement des leishmanioses cutanées de l'Ancien Monde: revue critique. Médecine et Maladies Infectieuses 9, 360-8.
10. Neal, R. A. (1964). Chemotherapy of cutaneous leishmaniasis: Leishmania tropica infections in mice. Annals of Tropical Medicine and Parasitology 58, 420-30.
11. Furtado, T. A. (1968). An appraisal of chemotherapy of American leishmaniasis. Dermatologia Ibero Latino-Americana 3, 257-68.
12. Simpson, L. & Simpson, A. M. (1978). Kinetoplast RNA of Leishmania tarentolae. Cell 14, 169-78.
13. Eeftinck-Schattenkerk, J.-K. M., Bhatt, S. M. & Rees, P. H. (1981). Antituberculous drugs and kala-azar. Lancet ii, 304.
14. Lindtjorn, B. (1981). Antituberculous drugs and kala-azar. Lancet ii, 304.
15. Akovbyan, A. A. & Mukhamedov, S. M. (1968). [Treatment of cutaneous leishmaniasis of the acute necrotising type (Borovskii's disease) with monomycin.] Vestnik Dermatologii i Venerologii 42(1), 74-6.
16. Ereshov, M. E. (1978). Therapeutic efficacy of monomycin against acutely necrotizing leishmaniasis with different administration regimes. Aktualnye Voprosy Meditsinskat Parasitologii (in Russian), 49-52.
17. Rocha, R. A. A., Sampaio, R. N., Guerra, M., Magalhâes, A., Cuba, C. C., Barreto, A. C. et al. (1980). Apparent glucantime failure in five patients with mucocutaneous leishmaniasis. Journal of Tropical Medicine and Hygiene 83, 131-9.
18. Baumann, R. J., McCann, P. P. & Bitonti, A. J. (1991). Suppression of Leishmania donovani by oral administration of a bis(benzyl)polyamine analog. Antimicrobial Agents and Chemotherapy 35, 1403-7.
19. Balana-Fouce, R., Escribano, M. I. & Alunda, J. M. (1991). Putrescine uptake regulation in response to alpha-difluoromethylornithine treatment in Leishmania infantum promastigotes. Molecular and Cellular Biochemistry 107, 127-33.
20. Marr, J. J. (1991). Purine analogs as chemotherapeutic agents in leishmaniasis and American trypanosomiasis. Journal of Laboratory and Clinical Medicine 118, 111-9.
21. Moorman, A. R., LaFon, S. W., Nelson, D. J., Carter, H. H., Marr, J. J. & Berens, R. L. (1991). Antiprotozoal activity of 3′-deoxyinosine. Inverse correlation to cleavage of the glycosidic bond. Biochemical Pharmacology 42, 207-12.
22. Ram, V. J., Haque, N. & Guru, P. Y. (1992). Chemotherapeutic agents XXV: synthesis and leishmanicidal activity of carbazolypyrimidines. European Journal of Medicinal Chemistry 27, 851-5.
23. Veiga, J. P. R., Rosa, T. T., Kimachi, T., Wolff, E. R., Sampaio, R. N., Gagliardi, A. R. T. et al. (1985). Funçao renal em pacientes com leishmaniose muco-cutanea tratados com antimoniais pentavalentes. Revista do Instituto de Medicina Tropical de Sao Paulo 27, 298-302.
24. Braconier, J. H. & Miorner, H. (1993). Recurrent episodes of thrombocytopenia during treatment with sodium stibogluconate. Journal of Antimicrobial Chemotherapy 31, 187-8.
25. Mesa-Valle, C. M., Craciunescu, D., Parriondo-lglesias, E. & Osuna, A. (1989). In vitro action of platinum(II) and platinum(IV) complexes on Trypanosoma cruzi and Leishmania donovani. Arzneimittel-Forschung/Drug Research 39, 838-42.
26. Fulford, D. E., Bradley, S. G. & Marciano-Cabral, F. (1985). Cytopathogenicity of Naegleria fowleri for cultured rat neuroblastoma cells. Journal of Protozoology 32, 176-80.
27. Osuna, A., Castanys, S., Ortega, G., Gamarro, F., Aneiros, J., Brana, M. F. et al. (1983). Estudio ultraestructural de la acción de dos derivados benzo(de)isoquinolil-1,3-diona sobre Trypanosoma cruzi in vitro. Revista do Institute de Medicina Tropical de Sao Paulo 25, 133-8.
28. Segovia Hernandez, M., Canteras Jordana, M. & Arterio Galan, J. M. (1984). Leishmaniasis experimental. I. Estudio de la infección cutánea y visceral en ratones BALB/C. Revista Iberica de Parasitologia 44, 265-78.
29. Chang, K. P. & Dwyer, D. M. (1976). Multiplication of a human parasite (Leishmania donovani) in phagolysosomes of hamster macrophages in vitro. Science 193, 678-80.
30. 1H] NMR characterization of amastigote-like forms. Molecular and Cellular Biochemistry 142, 89-97.
31. Mesa-Valle, C. M., Moraleda-Lindez, V., Craciunescu, D., Alonso, M. P. & Osuna, A. (1993). In vitro action of new organometallic compounds against Trypanosomatidae protozoa. Arzneimittel-Forschung/Drug Research 43, 1010-3.
32. Docampo, R. & Stoppani, A. O. M. (1980). Sobre el mecanismo de acción tripanocida de nifurtimox y otros nitroderivados en Trypanosoma cruzi. Medicina Buenos Aires 40, Suppl. 1, 10-6.
33. Docampo, R. & Moreno, S. N. J. (1984). Free radical metabolites in the mode of action of chemotherapeutic agents and phagocytic cells on Trypanosoma cruzi. Reviews of Infectious Diseases 6, 223-38.
34. Barreto-Bergter, E., Hogge, L. & Steele, da Cruz, F. (1986). Lipid alterations induced by nifurtimox in Trypanosoma cruzi. Molecular and Biochemical Parasitology 21, 221-6.
35. Foster, R. (1973). The preclinical development of oxamniquine. Revista do Institute de Medicina Tropical de Sao Paulo 15, Suppl. 1, 1-9.
36. Mediavilla, A. & Armijo, J. F. (1992) In Farmacologia Humana (Jesus Flores, Ed.). Ediciones Cientificas y Tecnicas S.A., Barcelona.
37. 14C]oxamniquine by Schistosoma mansoni. Parasitology 75, 111-8.
38. de Raadt, P. & Seed, J. R. (1977). Trypanosomes causing diseases in man in Africa. In Parasitic Protozoa, Vol. 1 (Kreier, J. P., Ed.), pp. 175-237. Academic Press, New York, NY.
39. Kaplan, H. G. & Myers, C. E. (1977). Complex inhibition of thymidylate synthetase by aromatic diamidines: evidence for both rapid, freely reversible and slowly progressive, nonequilibrium inhibition. Journal of Pharmacology and Experimental Therapeutics 201, 554-63.
40. 1 - Rh(l) o (Ir), NBR - norbornadieno y L = aniones xantatos. Anales de la Real Academia de Farmacia 56, 469-86.
41. Craciunescu, D. G., Molina, C., Doadrio-Villarejo J. C., Gutierrez-Rios, M. T., Alonso, M. P., Parrondo-lglesias, E. et al. (1991). Estudio de las actividades farmacológicas duales in vivo antitrpanosómicas y antitumorales) y de las toxicidades de algunos nuevos complejos neutros del Iridio (III). Anales de la Real Academia Farmacia 57, 391-418.
42. Craciunescu, D. G., Molina, C., Parrondo-lglesias, E., Alonso, M. P., Doadrio-Villarejo, J. C., Gutierrez-Rios, M. T. et al. (1992). Estudio de las actividades farmacológicas duales (antitripanosómicas y antitumorales) de los nuevos complejos neutres del Osmio (III), del Osmio (IV), y de los nuevos complejos anionicos del Rutenio (III). Anales de la Real Academia de Farmacia 58, 207-31.
43. Ruiz-Perez, L. M., Osuna, A., Castanys, S., Gamarro, F., Craciunescu, D. & Doadrio, A. (1986). Evaluation of the toxicity of Rh(III) and Pt(II) complexes against Trypanosoma cruzi culture forms. Arzneimittelforschung/Drug Research 36, 13-6.